Market Executive Summary
Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.
The global Liver Fibrosis Drug market size was US$ 11940 million in 2023 and is forecast to a readjusted size of US$ 10570 million by 2030 with a CAGR of -1.7% during the forecast period 2024-2030.
Global Liver Fibrosis Drug key players include Gilead, Biogen Idec, Merck KGaA, Bristol-Myers Squibb Company, Roche, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share about 50%, followed by Europe and Japan, both have a share about 30 percent.
In terms of product, Nucleoside is the largest segment, with a share over 45%. And in terms of application, the largest application is Hepatitis, followed by Liver Fibrosis.
In terms of sales (consumption) side, this report focuses on the sales of Liver Fibrosis Drug by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Liver Fibrosis Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Liver Fibrosis Drug market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
Global Liver Fibrosis Drug Companies Covered
Gilead, Biogen Idec, Merck KGaA, Bristol-Myers Squibb Company, Roche, Merck & Co., Tri-Prime
Global Liver Fibrosis Drug Market, Segment by Type
Nucleoside
Interferon
Other
Global Liver Fibrosis Drug Market, Segment by Application
Hepatitis
Liver Fibrosis
Other
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liver Fibrosis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Liver Fibrosis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Fibrosis Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Liver Fibrosis Drug Definition
1.2 Market by Type
1.2.1 Global Liver Fibrosis Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Nucleoside
1.2.3 Interferon
1.2.4 Other
1.3 Market Segment by Application
1.3.1 Global Liver Fibrosis Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hepatitis
1.3.3 Liver Fibrosis
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Liver Fibrosis Drug Sales
2.1 Global Liver Fibrosis Drug Revenue Estimates and Forecasts 2019-2030
2.2 Global Liver Fibrosis Drug Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Liver Fibrosis Drug Revenue by Region
2.3.1 Global Liver Fibrosis Drug Revenue by Region (2019-2024)
2.3.2 Global Liver Fibrosis Drug Revenue by Region (2025-2030)
2.4 Global Liver Fibrosis Drug Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Liver Fibrosis Drug Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Liver Fibrosis Drug Sales Quantity by Region
2.6.1 Global Liver Fibrosis Drug Sales Quantity by Region (2019-2024)
2.6.2 Global Liver Fibrosis Drug Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Liver Fibrosis Drug Sales Quantity by Manufacturers
3.1.1 Global Liver Fibrosis Drug Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Liver Fibrosis Drug Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Liver Fibrosis Drug Sales in 2023
3.2 Global Liver Fibrosis Drug Revenue by Manufacturers
3.2.1 Global Liver Fibrosis Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Liver Fibrosis Drug Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Liver Fibrosis Drug Revenue in 2023
3.3 Global Liver Fibrosis Drug Sales Price by Manufacturers
3.4 Global Key Players of Liver Fibrosis Drug, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Liver Fibrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Liver Fibrosis Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Liver Fibrosis Drug, Product Offered and Application
3.8 Global Key Manufacturers of Liver Fibrosis Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Liver Fibrosis Drug Sales Quantity by Type
4.1.1 Global Liver Fibrosis Drug Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Liver Fibrosis Drug Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
4.2 Global Liver Fibrosis Drug Revenue by Type
4.2.1 Global Liver Fibrosis Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Liver Fibrosis Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
4.3 Global Liver Fibrosis Drug Price by Type
4.3.1 Global Liver Fibrosis Drug Price by Type (2019-2024)
4.3.2 Global Liver Fibrosis Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Liver Fibrosis Drug Sales Quantity by Application
5.1.1 Global Liver Fibrosis Drug Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Liver Fibrosis Drug Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
5.2 Global Liver Fibrosis Drug Revenue by Application
5.2.1 Global Liver Fibrosis Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Liver Fibrosis Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
5.3 Global Liver Fibrosis Drug Price by Application
5.3.1 Global Liver Fibrosis Drug Price by Application (2019-2024)
5.3.2 Global Liver Fibrosis Drug Price Forecast by Application (2025-2030)
6 North America
6.1 North America Liver Fibrosis Drug Sales by Company
6.1.1 North America Liver Fibrosis Drug Revenue by Company (2019-2024)
6.1.2 North America Liver Fibrosis Drug Sales Quantity by Company (2019-2024)
6.2 North America Liver Fibrosis Drug Market Size by Type
6.2.1 North America Liver Fibrosis Drug Sales Quantity by Type (2019-2030)
6.2.2 North America Liver Fibrosis Drug Revenue by Type (2019-2030)
6.3 North America Liver Fibrosis Drug Market Size by Application
6.3.1 North America Liver Fibrosis Drug Sales Quantity by Application (2019-2030)
6.3.2 North America Liver Fibrosis Drug Revenue by Application (2019-2030)
6.4 North America Liver Fibrosis Drug Market Size by Country
6.4.1 North America Liver Fibrosis Drug Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Liver Fibrosis Drug Revenue by Country (2019-2030)
6.4.3 North America Liver Fibrosis Drug Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Liver Fibrosis Drug Sales by Company
7.1.1 Europe Liver Fibrosis Drug Sales Quantity by Company (2019-2024)
7.1.2 Europe Liver Fibrosis Drug Revenue by Company (2019-2024)
7.2 Europe Liver Fibrosis Drug Market Size by Type
7.2.1 Europe Liver Fibrosis Drug Sales Quantity by Type (2019-2030)
7.2.2 Europe Liver Fibrosis Drug Revenue by Type (2019-2030)
7.3 Europe Liver Fibrosis Drug Market Size by Application
7.3.1 Europe Liver Fibrosis Drug Sales Quantity by Application (2019-2030)
7.3.2 Europe Liver Fibrosis Drug Revenue by Application (2019-2030)
7.4 Europe Liver Fibrosis Drug Market Size by Country
7.4.1 Europe Liver Fibrosis Drug Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Liver Fibrosis Drug Revenue by Country (2019-2030)
7.4.3 Europe Liver Fibrosis Drug Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Liver Fibrosis Drug Sales by Company
8.1.1 China Liver Fibrosis Drug Sales Quantity by Company (2019-2024)
8.1.2 China Liver Fibrosis Drug Revenue by Company (2019-2024)
8.2 China Liver Fibrosis Drug Market Size by Type
8.2.1 China Liver Fibrosis Drug Sales Quantity by Type (2019-2030)
8.2.2 China Liver Fibrosis Drug Revenue by Type (2019-2030)
8.3 China Liver Fibrosis Drug Market Size by Application
8.3.1 China Liver Fibrosis Drug Sales Quantity by Application (2019-2030)
8.3.2 China Liver Fibrosis Drug Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Liver Fibrosis Drug Sales by Company
9.1.1 APAC Liver Fibrosis Drug Sales Quantity by Company (2019-2024)
9.1.2 APAC Liver Fibrosis Drug Revenue by Company (2019-2024)
9.2 APAC Liver Fibrosis Drug Market Size by Type
9.2.1 APAC Liver Fibrosis Drug Sales Quantity by Type (2019-2030)
9.2.2 APAC Liver Fibrosis Drug Revenue by Type (2019-2030)
9.3 APAC Liver Fibrosis Drug Market Size by Application
9.3.1 APAC Liver Fibrosis Drug Sales Quantity by Application (2019-2030)
9.3.2 APAC Liver Fibrosis Drug Revenue by Application (2019-2030)
9.4 APAC Liver Fibrosis Drug Market Size by Region
9.4.1 APAC Liver Fibrosis Drug Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Liver Fibrosis Drug Revenue by Region (2019-2030)
9.4.3 APAC Liver Fibrosis Drug Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Liver Fibrosis Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Liver Fibrosis Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Liver Fibrosis Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Liver Fibrosis Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Company Information
11.1.2 Gilead Overview
11.1.3 Gilead Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Gilead Liver Fibrosis Drug Products and Services
11.1.5 Gilead Liver Fibrosis Drug SWOT Analysis
11.1.6 Gilead Recent Developments
11.2 Biogen Idec
11.2.1 Biogen Idec Company Information
11.2.2 Biogen Idec Overview
11.2.3 Biogen Idec Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Biogen Idec Liver Fibrosis Drug Products and Services
11.2.5 Biogen Idec Liver Fibrosis Drug SWOT Analysis
11.2.6 Biogen Idec Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Overview
11.3.3 Merck KGaA Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Merck KGaA Liver Fibrosis Drug Products and Services
11.3.5 Merck KGaA Liver Fibrosis Drug SWOT Analysis
11.3.6 Merck KGaA Recent Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Information
11.4.2 Bristol-Myers Squibb Company Overview
11.4.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Bristol-Myers Squibb Company Liver Fibrosis Drug Products and Services
11.4.5 Bristol-Myers Squibb Company Liver Fibrosis Drug SWOT Analysis
11.4.6 Bristol-Myers Squibb Company Recent Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Overview
11.5.3 Roche Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Roche Liver Fibrosis Drug Products and Services
11.5.5 Roche Liver Fibrosis Drug SWOT Analysis
11.5.6 Roche Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Information
11.6.2 Merck & Co. Overview
11.6.3 Merck & Co. Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Merck & Co. Liver Fibrosis Drug Products and Services
11.6.5 Merck & Co. Liver Fibrosis Drug SWOT Analysis
11.6.6 Merck & Co. Recent Developments
11.7 Tri-Prime
11.7.1 Tri-Prime Company Information
11.7.2 Tri-Prime Overview
11.7.3 Tri-Prime Liver Fibrosis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Tri-Prime Liver Fibrosis Drug Products and Services
11.7.5 Tri-Prime Liver Fibrosis Drug SWOT Analysis
11.7.6 Tri-Prime Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Liver Fibrosis Drug Value Chain Analysis
12.2 Liver Fibrosis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liver Fibrosis Drug Production Mode & Process
12.4 Liver Fibrosis Drug Sales and Marketing
12.4.1 Liver Fibrosis Drug Sales Channels
12.4.2 Liver Fibrosis Drug Distributors
12.5 Liver Fibrosis Drug Customers
13 Market Dynamics
13.1 Liver Fibrosis Drug Industry Trends
13.2 Liver Fibrosis Drug Market Drivers
13.3 Liver Fibrosis Drug Market Challenges
13.4 Liver Fibrosis Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures
List of Tables
Table 1. Global Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Nucleoside
Table 3. Major Manufacturers of Interferon
Table 4. Major Manufacturers of Other
Table 5. Global Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Liver Fibrosis Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Liver Fibrosis Drug Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Liver Fibrosis Drug Revenue Market Share by Region (2019-2024)
Table 9. Global Liver Fibrosis Drug Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Liver Fibrosis Drug Revenue Market Share by Region (2025-2030)
Table 11. Global Liver Fibrosis Drug Sales Quantity by Region: 2019 VS 2023 VS 2030 (K Units)
Table 12. Global Liver Fibrosis Drug Sales by Region (2019-2024) & (K Units)
Table 13. Global Liver Fibrosis Drug Sales Market Share by Region (2019-2024)
Table 14. Global Liver Fibrosis Drug Sales by Region (2025-2030) & (K Units)
Table 15. Global Liver Fibrosis Drug Sales Market Share by Region (2025-2030)
Table 16. Global Liver Fibrosis Drug Sales Quantity by Manufacturers (2019-2024) & (K Units)
Table 17. Global Liver Fibrosis Drug Sales Quantity Share by Manufacturers (2019-2024)
Table 18. Global Liver Fibrosis Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Liver Fibrosis Drug Revenue Share by Manufacturers (2019-2024)
Table 20. Global Liver Fibrosis Drug Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Key Players of Liver Fibrosis Drug, Industry Ranking, 2022 VS 2023
Table 22. Global Liver Fibrosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Liver Fibrosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Fibrosis Drug as of 2023)
Table 24. Global Key Manufacturers of Liver Fibrosis Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Liver Fibrosis Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Liver Fibrosis Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Liver Fibrosis Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 29. Global Liver Fibrosis Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 30. Global Liver Fibrosis Drug Sales Quantity Share by Type (2019-2024)
Table 31. Global Liver Fibrosis Drug Sales Quantity Share by Type (2025-2030)
Table 32. Global Liver Fibrosis Drug Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Liver Fibrosis Drug Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Liver Fibrosis Drug Revenue Share by Type (2019-2024)
Table 35. Global Liver Fibrosis Drug Revenue Share by Type (2025-2030)
Table 36. Liver Fibrosis Drug Price by Type (2019-2024) & (USD/Unit)
Table 37. Global Liver Fibrosis Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 38. Global Liver Fibrosis Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 39. Global Liver Fibrosis Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 40. Global Liver Fibrosis Drug Sales Quantity Share by Application (2019-2024)
Table 41. Global Liver Fibrosis Drug Sales Quantity Share by Application (2025-2030)
Table 42. Global Liver Fibrosis Drug Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Liver Fibrosis Drug Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Liver Fibrosis Drug Revenue Share by Application (2019-2024)
Table 45. Global Liver Fibrosis Drug Revenue Share by Application (2025-2030)
Table 46. Liver Fibrosis Drug Price by Application (2019-2024) & (USD/Unit)
Table 47. Global Liver Fibrosis Drug Price Forecast by Application (2025-2030) & (USD/Unit)
Table 48. North America Liver Fibrosis Drug Revenue by Company (2019-2024) & (US$ Million)
Table 49. North America Liver Fibrosis Drug Sales Quantity by Company (2019-2024) & (K Units)
Table 50. North America Liver Fibrosis Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 51. North America Liver Fibrosis Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 52. North America Liver Fibrosis Drug Revenue by Type (2019-2024) & (US$ Million)
Table 53. North America Liver Fibrosis Drug Revenue by Type (2025-2030) & (US$ Million)
Table 54. North America Liver Fibrosis Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 55. North America Liver Fibrosis Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 56. North America Liver Fibrosis Drug Revenue by Application (2019-2024) & (US$ Million)
Table 57. North America Liver Fibrosis Drug Revenue by Application (2025-2030) & (US$ Million)
Table 58. North America Liver Fibrosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. North America Liver Fibrosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 60. North America Liver Fibrosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 61. North America Liver Fibrosis Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 62. North America Liver Fibrosis Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 63. Europe Liver Fibrosis Drug Sales Quantity by Company (2019-2024) & (K Units)
Table 64. Europe Liver Fibrosis Drug Revenue by Company (2019-2024) & (US$ Million)
Table 65. Europe Liver Fibrosis Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 66. Europe Liver Fibrosis Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 67. Europe Liver Fibrosis Drug Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Liver Fibrosis Drug Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Liver Fibrosis Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Europe Liver Fibrosis Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Europe Liver Fibrosis Drug Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Liver Fibrosis Drug Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Liver Fibrosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Liver Fibrosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Liver Fibrosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Liver Fibrosis Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 77. Europe Liver Fibrosis Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 78. China Liver Fibrosis Drug Sales Quantity by Company (2019-2024) & (K Units)
Table 79. China Liver Fibrosis Drug Revenue by Company (2019-2024) & (US$ Million)
Table 80. China Liver Fibrosis Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 81. China Liver Fibrosis Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 82. China Liver Fibrosis Drug Revenue by Type (2019-2024) & (US$ Million)
Table 83. China Liver Fibrosis Drug Revenue by Type (2025-2030) & (US$ Million)
Table 84. China Liver Fibrosis Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 85. China Liver Fibrosis Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 86. China Liver Fibrosis Drug Revenue by Application (2019-2024) & (US$ Million)
Table 87. China Liver Fibrosis Drug Revenue by Application (2025-2030) & (US$ Million)
Table 88. APAC Liver Fibrosis Drug Sales Quantity by Company (2019-2024) & (K Units)
Table 89. APAC Liver Fibrosis Drug Revenue by Company (2019-2024) & (US$ Million)
Table 90. APAC Liver Fibrosis Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 91. APAC Liver Fibrosis Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 92. APAC Liver Fibrosis Drug Revenue by Type (2019-2024) & (US$ Million)
Table 93. APAC Liver Fibrosis Drug Revenue by Type (2025-2030) & (US$ Million)
Table 94. APAC Liver Fibrosis Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 95. APAC Liver Fibrosis Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 96. APAC Liver Fibrosis Drug Revenue by Application (2019-2024) & (US$ Million)
Table 97. APAC Liver Fibrosis Drug Revenue by Application (2025-2030) & (US$ Million)
Table 98. APAC Liver Fibrosis Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 99. APAC Liver Fibrosis Drug Revenue by Region (2019-2024) & (US$ Million)
Table 100. APAC Liver Fibrosis Drug Revenue by Region (2025-2030) & (US$ Million)
Table 101. APAC Liver Fibrosis Drug Sales Quantity by Region (2019-2024) & (K Units)
Table 102. APAC Liver Fibrosis Drug Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Company (2019-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Company (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Type (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Type (2025-2030) & (K Units)
Table 107. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Type (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Type (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Application (2019-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Application (2025-2030) & (US$ Million)
Table 113. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 114. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 116. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Country (2019-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity by Country (2025-2030) & (K Units)
Table 118. Gilead Company Information
Table 119. Gilead Description and Overview
Table 120. Gilead Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 121. Gilead Liver Fibrosis Drug Product and Services
Table 122. Gilead Liver Fibrosis Drug SWOT Analysis
Table 123. Gilead Recent Developments
Table 124. Biogen Idec Company Information
Table 125. Biogen Idec Description and Overview
Table 126. Biogen Idec Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 127. Biogen Idec Liver Fibrosis Drug Product and Services
Table 128. Biogen Idec Liver Fibrosis Drug SWOT Analysis
Table 129. Biogen Idec Recent Developments
Table 130. Merck KGaA Company Information
Table 131. Merck KGaA Description and Overview
Table 132. Merck KGaA Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 133. Merck KGaA Liver Fibrosis Drug Product and Services
Table 134. Merck KGaA Liver Fibrosis Drug SWOT Analysis
Table 135. Merck KGaA Recent Developments
Table 136. Bristol-Myers Squibb Company Company Information
Table 137. Bristol-Myers Squibb Company Description and Overview
Table 138. Bristol-Myers Squibb Company Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 139. Bristol-Myers Squibb Company Liver Fibrosis Drug Product and Services
Table 140. Bristol-Myers Squibb Company Liver Fibrosis Drug SWOT Analysis
Table 141. Bristol-Myers Squibb Company Recent Developments
Table 142. Roche Company Information
Table 143. Roche Description and Overview
Table 144. Roche Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 145. Roche Liver Fibrosis Drug Product and Services
Table 146. Roche Liver Fibrosis Drug SWOT Analysis
Table 147. Roche Recent Developments
Table 148. Merck & Co. Company Information
Table 149. Merck & Co. Description and Overview
Table 150. Merck & Co. Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 151. Merck & Co. Liver Fibrosis Drug Product and Services
Table 152. Merck & Co. Liver Fibrosis Drug SWOT Analysis
Table 153. Merck & Co. Recent Developments
Table 154. Tri-Prime Company Information
Table 155. Tri-Prime Description and Overview
Table 156. Tri-Prime Liver Fibrosis Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 157. Tri-Prime Liver Fibrosis Drug Product and Services
Table 158. Tri-Prime Liver Fibrosis Drug SWOT Analysis
Table 159. Tri-Prime Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Liver Fibrosis Drug Distributors List
Table 163. Liver Fibrosis Drug Customers List
Table 164. Liver Fibrosis Drug Market Trends
Table 165. Liver Fibrosis Drug Market Drivers
Table 166. Liver Fibrosis Drug Market Challenges
Table 167. Liver Fibrosis Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Liver Fibrosis Drug Product Picture
Figure 2. Global Liver Fibrosis Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Liver Fibrosis Drug Market Share by Type in 2023 & 2030
Figure 4. Nucleoside Product Picture
Figure 5. Interferon Product Picture
Figure 6. Other Product Picture
Figure 7. Global Liver Fibrosis Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Liver Fibrosis Drug Market Share by Application in 2023 & 2030
Figure 9. Hepatitis
Figure 10. Liver Fibrosis
Figure 11. Other
Figure 12. Liver Fibrosis Drug Report Years Considered
Figure 13. Global Liver Fibrosis Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Liver Fibrosis Drug Revenue 2019-2030 (US$ Million)
Figure 15. Global Liver Fibrosis Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Liver Fibrosis Drug Sales Quantity 2019-2030 (K Units)
Figure 17. Global Liver Fibrosis Drug Sales Quantity Market Share by Region (2019-2024)
Figure 18. Global Liver Fibrosis Drug Sales Quantity Market Share by Region (2025-2030)
Figure 19. North America Liver Fibrosis Drug Sales Quantity YoY (2019-2030) & (K Units)
Figure 20. North America Liver Fibrosis Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Liver Fibrosis Drug Sales Quantity YoY (2019-2030) & (K Units)
Figure 22. Europe Liver Fibrosis Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Liver Fibrosis Drug Sales Quantity YoY (2019-2030) & (K Units)
Figure 24. China Liver Fibrosis Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 25. APAC Liver Fibrosis Drug Sales Quantity YoY (2019-2030) & (K Units)
Figure 26. APAC Liver Fibrosis Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Liver Fibrosis Drug Sales Quantity in 2023
Figure 30. The Top 10 and Top 5 Players Market Share by Liver Fibrosis Drug Revenue in 2023
Figure 31. Liver Fibrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
Figure 34. Global Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
Figure 36. North America Liver Fibrosis Drug Revenue Market Share by Company in 2023
Figure 37. North America Liver Fibrosis Drug Sales Quantity Market Share by Company in 2023
Figure 38. North America Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
Figure 40. North America Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
Figure 42. North America Liver Fibrosis Drug Revenue Share by Country (2019-2030)
Figure 43. North America Liver Fibrosis Drug Sales Quantity Share by Country (2019-2030)
Figure 44. U.S. Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 45. Canada Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 46. Europe Liver Fibrosis Drug Sales Quantity Market Share by Company in 2023
Figure 47. Europe Liver Fibrosis Drug Revenue Market Share by Company in 2023
Figure 48. Europe Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
Figure 49. Europe Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
Figure 50. Europe Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
Figure 51. Europe Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
Figure 52. Europe Liver Fibrosis Drug Revenue Share by Country (2019-2030)
Figure 53. Europe Liver Fibrosis Drug Sales Quantity Share by Country (2019-2030)
Figure 54. Germany Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 55. France Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 56. U.K. Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 57. Italy Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 58. Russia Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 59. China Liver Fibrosis Drug Sales Quantity Market Share by Company in 2023
Figure 60. China Liver Fibrosis Drug Revenue Market Share by Company in 2023
Figure 61. China Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. China Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
Figure 63. China Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. China Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
Figure 65. APAC Liver Fibrosis Drug Sales Quantity Market Share by Company in 2023
Figure 66. APAC Liver Fibrosis Drug Revenue Market Share by Company in 2023
Figure 67. APAC Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. APAC Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
Figure 69. APAC Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. APAC Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
Figure 71. APAC Liver Fibrosis Drug Revenue Share by Region (2019-2030)
Figure 72. APAC Liver Fibrosis Drug Sales Quantity Share by Region (2019-2030)
Figure 73. Japan Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 74. South Korea Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 75. China Taiwan Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 77. India Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity Market Share by Company in 2023
Figure 79. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue Market Share by Company in 2023
Figure 80. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity Market Share by Type (2019-2030)
Figure 81. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue Market Share by Type (2019-2030)
Figure 82. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity Market Share by Application (2019-2030)
Figure 83. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue Market Share by Application (2019-2030)
Figure 84. Middle East, Africa and Latin America Liver Fibrosis Drug Sales Quantity Share by Country (2019-2030)
Figure 85. Middle East, Africa and Latin America Liver Fibrosis Drug Revenue Share by Country (2019-2030)
Figure 86. Brazil Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 87. Mexico Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 88. Turkey Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 89. Israel Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 90. GCC Countries Liver Fibrosis Drug Revenue (2019-2030) & (US$ Million)
Figure 91. Liver Fibrosis Drug Value Chain
Figure 92. Liver Fibrosis Drug Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
